Reactive glia express cytosolic phospholipase A2 after transient global forebrain ischemia in the rat

Stroke

Volumn 27, Issue 3, 1996, Pages 527-535

  Clemens, James A ^a   Stephenson, Diane T ^a   Smalstig, E Barry ^a   Roberts, Edda F ^a   Johnstone, Edward M ^a   Sharp, John D ^a   Little, Sheila P ^a   Kramer, Ruth M ^a  

^a ELI LILLY AND COMPANY   (United States)

Author keywords

astrocytes; cerebral ischemia, global; occlusion; phospholipids; rats

Indexed keywords

PHOSPHOLIPASE A2;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASTROCYTE; BRAIN ISCHEMIA; CELL DEATH; CONTROLLED STUDY; ENZYME LOCALIZATION; FOREBRAIN; GLIA CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LIPID PEROXIDATION; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSIENT ISCHEMIC ATTACK;

EID: 0029940686     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.3.527     Document Type: Article

References (55)

1. Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res. 1982;239:57-69.
2. Pulsinelli WA, Brierley JB, Plum F. Temporal profile of neuronal damage in a model of transient forebrain global ischemia. Ann Neurol. 1982;11:491-498.
3. Schmidt-Kastner R, Szymas J, Hossmann K-A. Immunohistochemical study of glial reaction and serum-protein extravasation in relation to neuronal damage in rat hippocampus after ischemia. Neuroscience. 1990;38:527-540.
4. Morioka T, Kalehua AN, Streit WJ. The microglial reaction in the rat dorsal hippocampus following transient forebrain ischemia. J Cereb Blood Flow Metab. 1991;11:966-973.
5. Gehrmann J, Bonnekoh P, Miyazawa T, Hossman K-A, Kreutzberg GW. Immunocytochemical study of an early microglial activation in ischemia. J Cereb Blood Flow Metab. 1992;12:257-269.
6. Rehncrona S, Westerberg E, Akesson B, Siesjo BK. Brain cortical fatty acids and phospholipids during and following complete and severe incomplete ischemia. J Neurochem. 1982;38:84-93.
7. Yoshida S, Ikeda M, Busto R, Santiso M, Martinez E, Ginsberg M. Cerebral phophoinositide, triacylglycerol and energy metabolism in reversible ischemia: origin and fate of free fatty acids. J Neurochem. 1986;47:744-757.
8. Abe K, Kogure K, Yamamoto H, Imazawa M, Miyamoto K. Mechanism of arachidonic acid liberation during ischemia in gerbil cerebral cortex. J Neurochem. 1987;48:503-509.
9. Moskowitz MA, Kiwok KJ, Hekimian K, Levine L. Synthesis of compounds with properties of leukotrienes C4 and D4 in gerbil brains after ischemia and reperfusion. Science. 1984;224:886-888.
10. Kiwok KJ, Moskowitz MA, Levine L. Leukotriene production in gerbil brain after ischemic insult, subarachnoid hemorrhage, and concussive injury. J Neurosurg. 1985;62:865-869.
11. Kempski O, Skahami E, Von Lubitz D, Hallenbeck JM. Feuerstein G. Postischemic production of eicosanoids in gerbil brain. Stroke. 1987;18:111-119.
12. Usui M, Asano T, Takakura K. Identification and quantitative analysis of hydroxy-eicosatetraenoic acids in rat brains exposed to regional ischemia. Stroke. 1987;18:490-494.
13. Lindsberg PJ, Hallenbeck JM, Feuerstein G. Platelet-activating factor in stroke and brain injury. Ann Neurol. 1991;30:117-129.
14. Bromont C, Marie C, Bralet J. Increased lipid peroxidation in vulnerable brain regions after transient forebrain ischemia in rats. Stroke. 1989;20:918-924.
15. Bazan NG. Arachidonic acid in the modulation of excitable membrane function and at the onset of brain damage. Ann N Y Acad Sci. 1989;559:1-16.
16. 2 in human platelets. J Biol Chem. 1993;268:26796-26804.
17. 2. In: Liscovitch M, ed. Signal-Activated Phospholipases. Austin, Tex: RG Landes Co; 1994:13-30.
18. Kimura H, Okamoto K, Sakai Y. Modulatory effects of prostaglandin D2, E2 and F2alpha on the postsynaptic actions of inhibitory and excitatory amino acids in cerebellar Purkinje cell dendrites in vitro. Brain Res. 1985;330:235-244.
19. Kramer RM. Hession C, Johansen B, Hayes G, McGray P, Chow EP, Tizard R, Pepinsky RB. Structure and properties of a human non-pancreatic phospholipase A2. J Biol Chem. 1990;264: 5768-5775.
20. 2 contains a Ca(2+)-dependent translocation domain with homology to PKC and GAP. Cell. 1991;65:1043-1051.
21. Clark JD, Milona N, Knopf JL. Purification of a 110-kilodalton cytosolic phospholipase A2 from the human monocytic cell line U937. Proc Natl Acad Sci USA. 1990;87:7708-7712.
22. 2 is a 100-kDa protein in human monoblast U937 cells. J Biol Chem. 1991;266:5268-5272.
23. 2+-sensitive cytosolic phospholipase A2. J Biol Chem. 1991;266:14850-14853.
24. 2 from macrophage-like P388D1 cells. J Biol Chem. 1994;269:9227-9233.
25. 2 and their membrane substrates. Trends Cardiovasc Med. 1992;2:115-121.
26. 2 is expressed in human brain astrocytes. Brain Res. 1994;637:97-105.
27. Pulsinelli WA, Brierley JB. A new model of bilateral hemispheric ischemia in the unanesthetized rat. Stroke. 1979;10:267-272.
28. Bignami A, Dahl D. Astrocyte-specific protein and radial glia in the cerebral cortex of newborn rat. Nature. 1974;252:55-56.
29. Graeber MB, Tetzlaff W, Streit WJ, Kreutzberg GW. Microglial cells but not astrocytes undergo mitosis following rat facial nerve axotomy. Neurosci Lett. 1988;85:317-321.
30. Dijkstra CD, Doepp EA, Joling P, Draal G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognised by monoclonal antibodies ED1, ED2 and ED3. Immunology. 1985;54:589-599.
31. Flaris NA, Densmore TL, Molleston MC, Hickey WF. Characterization of microglia and macrophages in the central nervous system of rats: definitton of the differential expression of molecules using standard and novel monoclonal antibodies in normal CNS and in four models of parenchymal reaction. Glia. 1993;7:34-40.
32. Sminia T, De Groot CJA, Dijkstra CD, Koetsier JC, Polman CH. Macrophages in the central nervous system of the rat. Immunobiology. 1987;174:43-50.
33. 2. Biochem Biophys Res Commun. 1992;187:544-551.
34. Kirino T, Tamura A, Sano K. Delayed neuronal death in the rat hippocampus following transient forebrain ischemia. Acta Neuropathol (Berl). 1984;64:139-147.
35. Pulsinelli WA. Selective neuronal vulnerability: morphological and molecular characteristics. Prog Brain Res. 1985;63:29-37.
36. Schmidt-Kastner R, Freund TF. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience. 1991;40:599-636.
37. Ordy JM, Wengenack TM, Bialobok P, Coleman PD, Kodier P, Baggs RB, Dunlap WP, Kates B. Selective vulnerability and early progression of hippocampal CA1 pyramidal cell degeneration and GFAP-positive astrocyte reactivity in the rat four-vessel occlusion model of transient global ischemia. Exp Neurol. 1993; 119:128-139.
38. Petito CK, Halaby IA. Relationship between ischemia and ischemic neuronal necrosis to astrocyte expression of glial fibrillary acidic protein. Int J Dev Neurosci. 1993;11:239-247.
39. Lees GJ. The possible contribution of microglia and macrophages to delayed neuronal death after ischemia. J Neurol Sci. 1993;114: 119-122.
40. Giulian D, Vaca K. Inflammatory glia mediate delayed neuronal damage after ischemia in the central nervous system. Stroke. 1993; 24:184-190.
41. Banati RB, Gehrmann J, Schubert P, Kreutzberg GW. Cytotoxicity of microglia. Glia. 1993;7:111-118.
42. Sa G, Murugesan G, Jaye M, Ivashchendo Y, Fox PL. Activation of cytosolic phospholipase A2 by basic fibroblast growth factor via a p42 mitogen-activated protein kinase-dependent phosphorylation pathway in endothelial cells. J Biol Chem. 1995;270: 2360-2366.
43. Whatley RE, Satoh K, Zimmerman GA, McIntyre TM, Prescott SM. Proliferation-dependent changes in release of arachidonic acid from endothelial cells. J Clin Invest. 1994;94:1889-1900.
44. Owada Y, Tominaga T, Yoshimoto T, Kondo H. Molecular cloning of rat cDNA for cytosolic phospholipase A2 and the increased gene expression in the dentate gyrus following transient forebrain ischemia. Mol Brain Res. 1994;25:364-368.
45. 2 in brain during ischemia. J Neurochem. 1982;39:1111-1116.
46. Rordorf G, Uemura Y, Bonventre JV. Characterization of phospholipase A2 activity in gerbil brain: enhanced activities of cytosolic, mitochondrial and microsomal forms after ischemia and reperfusion. J Neurosci. 1991;11:1829-1836.
47. Dempsey RJ, Roy MW, Meyer K, Cowen DE, Tai H-H. Development of cyclooxygenase and lipoxygenase metabolites of arachidonic acid after transient cerebral ischemia. J Neurosurg. 1986;64: 118-124.
48. Nedergaard M. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science. 1994;263:1768-1771.
49. Panetta JA, Clemens JA. Pathophysiology of reperfusion injury in brain. In: Das DK, ed. Pathophysiology of Reperfusion Injury. Boca Raton, Fla: CRC Press, Inc; 1993:377-394.
50. 2 in vitro. Brain Res. 1995;671:181-186.
51. Rao GN, Runge MS, Alexander RW. Hydrogen peroxide activation of cytosolic phopholipase A2 in vascular smooth muscle cells. Biochim Biophys Acta. 1995;1265:67-72.
52. Kontos HA. Oxygen radicals from arachidonate metabolism in abnormal vascular responses. Am Rev Respir Dis. 1987;136: 474-477.
53. Chan PH, Fishman RA. Alterations of membrane integrity and cellular constituents by arachidonic acid in neuroblastoma and glioma cells. Brain Res. 1982;248:151-157.
54. Chan PH, Yurko M, Fishman RA. Phospholipid degradation and cellular edema induced by free radicals in brain cortical slices. J Neurochem. 1982;38:525-531.
55. 2 activity by oxygen-derived free radicals in isolated brain capillaries. J Cell Biochem. 1985;27:449-453.